---
figid: PMC9375293__13048_2022_1022_Fig1_HTML
figtitle: Targeting purine metabolism in ovarian cancer
organisms:
- NA
pmcid: PMC9375293
filename: 13048_2022_1022_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9375293/figure/Fig1/
number: F1
caption: 'De novo, salvage and degradation pathways of purine nucleotides under the
  regulation of purine-metabolizing enzymes. The de novo pathway converts PRPP to
  IMP and, ultimately, GMP and AMP that further involve in nucleotide synthesis. The
  salvage pathway recovers purine bases and purine nucleosides to generate purine
  nucleotides. The degraded purine base becomes Xan with eventual conversion to UA.
  Cyan: de novo pathway; red: salvage pathway; yellow: degradation pathway; gradient
  color: involved in multiple metabolic pathways; arrows: purine metabolic pathways;
  squares: purine-metabolizing enzymes involved in related pathways. R-5-P: ribose
  5-phosphate; PRPP: 5-phosphoribosyl-1-pyrophosphate; Gln: glutamine; THF: Tetrahydrofolate;
  Asp: aspartate; Hyp: hypoxanthine; Ino: Inosine; IMP: inosine monophosphate; Xan:
  xanthine; XMP: xanthosine monophosphate; Gua: guanine; GMP: guanosine monophosphate;
  Ade: adenine; Ado: adenosine; AMP: ado monophosphate; SAMP: succinyl-AMP; UA: uric
  acid; PPAT: phosphoribosyl pyrophosphate amidotransferase; IMPDH: IMP dehydrogenase;
  GMPS: GMP synthase; ADSS: adenylosuccinate synthase; ADSL: adenylosuccinate lyase;
  HPRT: Hyp Gua phosphoribosyltransferase; APRT: Ade phosphoribosyltransferase; ADA:
  Ado deaminase; AK: adenylate kinase; PNP: purine nucleoside phosphorylase; XO: xanthine
  oxidase'
papertitle: Targeting purine metabolism in ovarian cancer.
reftext: Jingchun Liu, et al. J Ovarian Res. 2022;15:93.
year: '2022'
doi: 10.1186/s13048-022-01022-z
journal_title: Journal of Ovarian Research
journal_nlm_ta: J Ovarian Res
publisher_name: BioMed Central
keywords: Purine metabolism | Ovarian cancer | Metabolizing enzyme | Antimetabolites
  | Purinergic signaling
automl_pathway: 0.9306309
figid_alias: PMC9375293__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9375293__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9375293__13048_2022_1022_Fig1_HTML.html
  '@type': Dataset
  description: 'De novo, salvage and degradation pathways of purine nucleotides under
    the regulation of purine-metabolizing enzymes. The de novo pathway converts PRPP
    to IMP and, ultimately, GMP and AMP that further involve in nucleotide synthesis.
    The salvage pathway recovers purine bases and purine nucleosides to generate purine
    nucleotides. The degraded purine base becomes Xan with eventual conversion to
    UA. Cyan: de novo pathway; red: salvage pathway; yellow: degradation pathway;
    gradient color: involved in multiple metabolic pathways; arrows: purine metabolic
    pathways; squares: purine-metabolizing enzymes involved in related pathways. R-5-P:
    ribose 5-phosphate; PRPP: 5-phosphoribosyl-1-pyrophosphate; Gln: glutamine; THF:
    Tetrahydrofolate; Asp: aspartate; Hyp: hypoxanthine; Ino: Inosine; IMP: inosine
    monophosphate; Xan: xanthine; XMP: xanthosine monophosphate; Gua: guanine; GMP:
    guanosine monophosphate; Ade: adenine; Ado: adenosine; AMP: ado monophosphate;
    SAMP: succinyl-AMP; UA: uric acid; PPAT: phosphoribosyl pyrophosphate amidotransferase;
    IMPDH: IMP dehydrogenase; GMPS: GMP synthase; ADSS: adenylosuccinate synthase;
    ADSL: adenylosuccinate lyase; HPRT: Hyp Gua phosphoribosyltransferase; APRT: Ade
    phosphoribosyltransferase; ADA: Ado deaminase; AK: adenylate kinase; PNP: purine
    nucleoside phosphorylase; XO: xanthine oxidase'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IMPA1
  - BRAP
  - EMP2
  - ADSS2
  - PPAT
  - COASY
  - GMPS
  - HPRT1
  - XPNPEP1
  - ADA
  - ADAD1
  - ADAD2
  - ADAR
  - ADARB1
  - ADARB2
  - ADAT1
  - ADAT2
  - ADAT3
  - NT5C2
  - PNP
  - PPY
  - ADSL
  - ADO
  - DDX21
  - APRT
  - MFAP1
  - NT5E
---
